Published in

Wiley, FEBS Letters, 3(508), p. 313-317, 2001

DOI: 10.1016/s0014-5793(01)03077-0

Links

Tools

Export citation

Search in Google Scholar

The serine protease inhibitor antithrombin III inhibits LPS-mediated NF-κB activation by TLR-4

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

In Drosophila, the Toll family of proteins mediates the innate immune response. Toll is activated by Spaetzle, which is generated in response to pathogens via a serine protease cascade. We wished to investigate if lipopolysaccharides (LPS) might activate Toll-like receptor (TLR) 4 via a serine protease in humans. The serpin antithrombin III (ATIII) and the thrombin inhibitor hirudin both inhibited nuclear factor (NF)-κB activation by LPS and Lipid A. ATIII and hirudin were also able to inhibit LPS-induced NF-κB activation in cells stably transfected with TLR4. These results suggest that LPS may activate a mammalian serine protease, which generates a product required for TLR4 signalling.